Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer

• Published in: PloS one 2020-11, Vol.15 (11), p.e0242806-e0242806
• Main Authors: Yoon, Jiyoung, Lee, Eunjung, Koo, Ja Seung, Yoon, Jung Hyun, Nam, Kee-Hyun, Lee, Jandee, Jo, Young Suk, Moon, Hee Jung, Park, Vivian Youngjean, Kwak, Jin Young
• Format: Article
• Language: English
• Subjects: Adult; Aged; Artificial Intelligence; Artificial neural networks; Biology and Life Sciences; Biopsy; Calcification; Cancer; Carcinoma, Papillary - diagnosis; Carcinoma, Papillary - epidemiology; Carcinoma, Papillary - genetics; Carcinoma, Papillary - pathology; Cellular biology; Computer and Information Sciences; Cysts; Deep learning; Demographics; Demography; Diagnosis, Computer-Assisted; Female; Hospitals; Humans; Male; Malignancy; Medical diagnosis; Medical imaging; Medical schools; Medicine; Medicine and Health Sciences; Middle Aged; Multivariate analysis; Mutation; Mutation - genetics; Neural networks; Pathology; Patients; People and Places; Proto-Oncogene Proteins B-raf - genetics; Radiology; Regression analysis; Research and Analysis Methods; Surgery; Thyroid; Thyroid cancer; Thyroid Gland - diagnostic imaging; Thyroid Gland - pathology; Thyroid Neoplasms - diagnostic imaging; Thyroid Neoplasms - epidemiology; Thyroid Neoplasms - genetics; Thyroid Neoplasms - pathology; Thyroid Nodule; Tomography, X-Ray Computed
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0242806

To investigate whether a computer-aided diagnosis (CAD) program developed using the deep learning convolutional neural network (CNN) on neck US images can predict the BRAFV600E mutation in thyroid cancer. 469 thyroid cancers in 469 patients were included in this retrospective study. A CAD program recently developed using the deep CNN provided risks of malignancy (0-100%) as well as binary results (cancer or not). Using the CAD program, we calculated the risk of malignancy based on a US image of each thyroid nodule (CAD value). Univariate and multivariate logistic regression analyses were performed including patient demographics, the American College of Radiology (ACR) Thyroid Imaging, Reporting and Data System (TIRADS) categories and risks of malignancy calculated through CAD to identify independent predictive factors for the BRAFV600E mutation in thyroid cancer. The predictive power of the CAD value and final multivariable model for the BRAFV600E mutation in thyroid cancer were measured using the area under the receiver operating characteristic (ROC) curves. In this study, 380 (81%) patients were positive and 89 (19%) patients were negative for the BRAFV600E mutation. On multivariate analysis, older age (OR = 1.025, p = 0.018), smaller size (OR = 0.963, p = 0.006), and higher CAD value (OR = 1.016, p = 0.004) were significantly associated with the BRAFV600E mutation. The CAD value yielded an AUC of 0.646 (95% CI: 0.576, 0.716) for predicting the BRAFV600E mutation, while the multivariable model yielded an AUC of 0.706 (95% CI: 0.576, 0.716). The multivariable model showed significantly better performance than the CAD value alone (p = 0.004). Deep learning-based CAD for thyroid US can help us predict the BRAFV600E mutation in thyroid cancer. More multi-center studies with more cases are needed to further validate our study results.